Laboratory Corp. of America Stock Price, News & Analysis (NYSE:LH)

$172.69
+1.58 (+0.92 %)
(As of 09/22/2019 01:35 AM ET)
Today's Range
$170.91
Now: $172.69
$173.80
50-Day Range
$159.36
MA: $167.63
$174.67
52-Week Range
$119.38
Now: $172.69
$178.44
Volume512,542 shs
Average Volume472,788 shs
Market Capitalization$16.87 billion
P/E Ratio15.67
Dividend YieldN/A
Beta1.04
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.33 billion
Cash Flow$16.8150 per share
Book Value$69.09 per share

Profitability

Net Income$883.70 million

Miscellaneous

Employees61,000
Market Cap$16.87 billion
Next Earnings Date10/23/2019 (Estimated)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) announced its earnings results on Thursday, July, 25th. The medical research company reported $2.93 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.90 by $0.03. The medical research company earned $2.88 billion during the quarter, compared to analysts' expectations of $2.89 billion. Laboratory Corp. of America had a net margin of 8.19% and a return on equity of 16.28%. The firm's revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.98 earnings per share. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America updated its FY 2019 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $11.10-11.40 for the period, compared to the Thomson Reuters consensus estimate of $11.27. The company issued revenue guidance of $11.4433-11.5566 billion, compared to the consensus revenue estimate of $11.47 billion.

What price target have analysts set for LH?

18 analysts have issued twelve-month price objectives for Laboratory Corp. of America's shares. Their predictions range from $164.00 to $220.00. On average, they anticipate Laboratory Corp. of America's share price to reach $185.9733 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 1 sell rating, 6 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

Media stories about LH stock have been trending somewhat negative this week, InfoTrie reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Laboratory Corp. of America earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news articles about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Laboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a decrease in short interest in the month of August. As of August 15th, there was short interest totalling 1,646,300 shares, a decrease of 13.6% from the July 15th total of 1,905,900 shares. Based on an average trading volume of 729,500 shares, the short-interest ratio is presently 2.3 days. Approximately 1.6% of the company's stock are sold short. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Micron Technology (MU), Endologix (ELGX), Amgen (AMGN), NVIDIA (NVDA), Allergan (AGN), Chipotle Mexican Grill (CMG), Cisco Systems (CSCO) and Intel (INTC).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.01%), BlackRock Inc. (9.16%), BlackRock Inc. (9.08%), Boston Partners (2.49%), UBS Asset Management Americas Inc. (1.66%) and JPMorgan Chase & Co. (1.64%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Der Vaart Sandra D Van, Dwight Gary Gilliland, Edward T Dodson, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which major investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., BlackRock Inc., AQR Capital Management LLC, Boston Partners, First Trust Advisors LP, Renaissance Technologies LLC, Bank of America Corp DE and Bessemer Group Inc.. Company insiders that have sold Laboratory Corp. of America company stock in the last year include Der Vaart Sandra D Van, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Which major investors are buying Laboratory Corp. of America stock?

LH stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., Balyasny Asset Management LLC, LSV Asset Management, Wedge Capital Management L L P NC, AMI Asset Management Corp, California Public Employees Retirement System and Iridian Asset Management LLC CT. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $172.69.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $16.87 billion and generates $11.33 billion in revenue each year. The medical research company earns $883.70 million in net income (profit) each year or $11.02 on an earnings per share basis. Laboratory Corp. of America employs 61,000 workers across the globe.View Additional Information About Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  470 (Vote Outperform)
Underperform Votes:  506 (Vote Underperform)
Total Votes:  976
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Featured Article: Trade War

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel